Biobehavioral stress reduction for patients with triple negative breast cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the feasibility of a biobehavioral stress reduction program for patients with newly diagnosed triple negative breast cancer. Over ten weeks, participants will engage in stress reduction techniques, coping strategies, and receive support for health-related social needs. The study will assess patient satisfaction, tolerability, and feasibility through various metrics, including completion rates and biological markers related to stress. Additionally, the impact on psychological symptoms and stress levels will be explored through pre- and post-intervention assessments.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \>=18 years
* Untreated newly diagnosed triple negative breast cancer
* Stages I-III

Exclusion Criteria:

* Prisoners
* Male
* Identifying as American Indian, Alaska Native, Asian, Native Hawaiian or Other Pacific Islander
* Individuals not able to speak and understand English
* Known personal history of ductal carcinoma in situ (DCIS) or invasive breast cancer
* Stage IV breast cancer

Where it's running

• MetroHealth
  Cleveland, Ohio, United States Recruiting
• Ohio State University Comprehensive Cancer Center
  Columbus, Ohio, United States Recruiting

Study contacts

• Principal investigator: Samilia Obeng-Gyasi, MD, MPH — Ohio State University Comprehensive Cancer Center
• Study coordinator: The Ohio State Comprehensive Cancer Center
• Email: OSUCCCClinicaltrials@osumc.edu
• Phone: 800-293-5066

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression

  This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.

  Recruiting at 11 sites City of Hope Medical Center · Arcadia, California and 10 other locations · NCT07741968

• Hypofractionated radiotherapy for non-metastatic breast cancer treatment

  This study is testing if giving a shorter course of radiation therapy before or after surgery can help women with non-metastatic breast cancer while causing fewer severe side effects.

  Recruiting Phase 2 Mayo Clinic · Scottsdale, Arizona · NCT06635980

• Using acupuncture and acupressure to reduce joint pain in Black women with early-stage breast cancer

  This study is testing whether acupuncture and virtual acupressure can help reduce joint pain for Black women with early-stage breast cancer who are taking hormone therapy.

  Recruiting at 4 sites Emory University · Atlanta, Georgia and 3 other locations · NCT06534125

• Dose-reduced chemotherapy for older women with early-stage HER2 negative breast cancer

  This study is testing if a lower dose of chemotherapy can help older women with early-stage HER2 negative breast cancer feel better during treatment compared to the standard dose.

  Recruiting at 3 sites Phase 2 City of Hope Medical Center · Duarte, California and 2 other locations · NCT06042569

• Combining letrozole and simvastatin to treat hormone receptor positive breast cancer

  This study tests if combining letrozole with simvastatin can help shrink tumors in postmenopausal women with hormone receptor positive breast cancer better than using letrozole alone.

  Recruiting at 4 sites Early Phase 1 Emory University · Atlanta, Georgia and 3 other locations · NCT05464810

• Navigation program to boost survivorship support participation for non-metastatic breast cancer survivors

  This program tests whether a patient navigation service helps non-metastatic breast cancer survivors use survivorship support services more often.

  Recruiting Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT07699991

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.